Geographic variation in prostate cancer survival in new south wales

Medical Journal of Australia

Volumn 200, Issue 10, 2014, Pages 586-590

  Yu, Xue Qin ^a   Luo, Qingwei ^a   Smith, David P ^a   O'Connell, Dianne L ^a   Baade, Peter D ^b  

^a CANCER RESEARCH DIVISION   (Australia)

^b VIERTEL CENTRE FOR RESEARCH IN CANCER CONTROL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; GEOGRAPHY; HEALTH SERVICES ACCESSIBILITY; HEALTHCARE DISPARITIES; HUMANS; MALE; MIDDLE AGED; NEW SOUTH WALES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RURAL POPULATION; SOCIOECONOMIC FACTORS; SURVIVAL ANALYSIS; URBAN POPULATION; YOUNG ADULT;

EID: 84904471561     PISSN: 0025729X     EISSN: 13265377     Source Type: Journal    
DOI: 10.5694/mja13.11134     Document Type: Article

References (25)

1. Baade PD, Youlden DR, Coory MD, et al. Urbanrural diff erences in prostate cancer outcomes in Australia: what has changed? Med J Aust 2011; 194: 293-296.
2. Cramb SM, Mengersen KL, Turrell G, Baade PD. Spatial inequalities in colorectal and breast cancer survival: premature deaths and associated factors. Health Place 2012; 18: 1412-1421.
3. Dasgupta P, Baade PD, Aitken JF, Turrell G. Multilevel determinants of breast cancer survival: association with geographic remoteness and area-level socioeconomic disadvantage. Breast Cancer Res Treat 2012; 132: 701-710.
4. Yu XQ, O'Connell DL, Gibberd RW, Armstrong BK. A population-based study from New South Wales, Australia 1996-2001: area variation in survival from colorectal cancer. Eur J Cancer 2005; 41: 2715-2721.
5. Yu XQ, O'Connell DL, Gibberd RW, Armstrong BK. Assessing the impact of socio-economic status on cancer survival in New South Wales, Australia 1996-2001. Cancer Causes Control 2008; 19: 1383-1390.
6. Jong KE, Smith DP, Yu XQ, et al. Remoteness of residence and survival from cancer in New South Wales. Med J Aust 2004; 180: 618-622.
7. Newman L, Baum F, Harris E. Federal, state and territory government responses to health inequities and the social determinants of health in Australia. Health Promot J Austr 2006; 17: 217-225.
8. Australian Bureau of Statistics. ASGC Remoteness Classifi cation: purpose and use. Canberra: Commonwealth of Australia, 2003.
9. Gregorio DI, Kulldorff M, Sheehan TJ, Samociuk H. Geographic distribution of prostate cancer incidence in the era of PSA testing, Connecticut, 1984 to 1998. Urology 2004; 63: 78-82.
10. Australian Bureau of Statistics. Information paper: An Introduction to Socio-Economic Indexes for Areas (SEIFA), 2006. Canberra: ABS, 2008.
11. Brenner H. Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis. Lancet 2002; 360: 1131-1135.
12. Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004; 23: 51-64.
13. Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: comparative eff ectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008; 148: 435-448.
14. Branney P, White A, Jain S, et al. Choosing health, choosing treatment: patient choice after diagnosis of localized prostate cancer. Urology 2009; 74: 968-971.
15. Cox J, Amling CL. Current decision-making in prostate cancer therapy. Curr Opin Urol 2008; 18: 275-278.
16. Singh J, Trabulsi EJ, Gomella LG. The quality-oflife impact of prostate cancer treatments. Curr Urol Rep 2010; 11: 139-146.
17. Trock BJ, Han M, Freedland SJ, et al. Prostate cancer-specifi c survival following salvage radiotherapy vs observation in men with biochemical recurrence after radical prostatectomy. JAMA 2008; 299: 2760-2769.
18. Hayen A, Smith DP, Patel MI, O'Connell DL. Patterns of surgical care for prostate cancer in NSW, 1993-2002: rural/urban and socioeconomic variation. Aust N Z J Public Health 2008; 32: 417-420.
19. Hall SE, Holman CD, Wisniewski ZS, Semmens J. Prostate cancer: socio-economic, geographical and private-health insurance eff ects on care and survival. BJU Int 2005; 95: 51-58.
20. Baade PD, Youlden DR, Gardiner RA, et al. Factors associated with treatment received by men diagnosed with prostate cancer in Queensland, Australia. BJU Int 2012; 110: E712-E719.
21. Lu-Yao GL, Greenberg ER. Changes in prostate cancer incidence and treatment in USA. Lancet 1994; 343: 251-254.
22. Chu DI, Freedland SJ. Prostate cancer. Socioeconomic status and disparities in treatment patterns. Nat Rev Urol 2010; 7: 480-481.
23. Wan N, Zhan FB, Cai Z. Socioeconomic disparities in prostate cancer mortality and the impact of geographic scale. South Med J 2011; 104: 553-559.
24. Evans SM, Millar JL, Davis ID, et al. Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011. Med J Aust 2013; 198: 540-555.
25. Smith DP, Supramaniam R, Marshall VR, Armstrong BK. Prostate cancer and prostatespecifi c antigen testing in New South Wales. Med J Aust 2008; 189: 315-318.